MDX-1106

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MDX-1106, covering 2010-04-23 to 2015-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies [Phase 1]